BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9364505)

  • 1. Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice.
    Dematteis M; Mallaret M; Baubichon D; Pernot-Marino I; Lallement G
    Neurosci Lett; 1997 Oct; 234(2-3):91-4. PubMed ID: 9364505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.
    Dematteis M; Lallement G; Mallaret M
    Fundam Clin Pharmacol; 1998; 12(5):526-37. PubMed ID: 9794151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters.
    Richter A; Löscher W
    Brain Res; 1997 Jan; 745(1-2):336-8. PubMed ID: 9037429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice.
    Kim HC; Bing G; Jhoo WK; Kim WK; Shin EJ; Im DH; Kang KS; Ko KH
    Life Sci; 2003 Jan; 72(7):769-83. PubMed ID: 12479976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of soman neurotoxicity by non-opioid antitussives.
    Sparenborg S; Brennecke LH; Braitman DJ
    Neurotoxicology; 1990; 11(3):509-20. PubMed ID: 2284055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.
    Kim HC; Shin CY; Seo DO; Jhoo JH; Jhoo WK; Kim WK; Shin EJ; Lee YH; Lee PH; Ko KH
    Life Sci; 2003 Mar; 72(16):1883-95. PubMed ID: 12586225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile.
    Tortella FC; Robles L; Witkin JM; Newman AH
    J Pharmacol Exp Ther; 1994 Feb; 268(2):727-33. PubMed ID: 8113984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices.
    Wong BY; Coulter DA; Choi DW; Prince DA
    Neurosci Lett; 1988 Feb; 85(2):261-6. PubMed ID: 2897648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan.
    Kim HC; Ko KH; Kim WK; Shin EJ; Kang KS; Shin CY; Jhoo WK
    Behav Brain Res; 2001 May; 120(2):169-75. PubMed ID: 11182165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of dextromethorphan and carbetapentane as anticonvulsants and N-methyl-D-aspartic acid antagonists in mice.
    Leander JD
    Epilepsy Res; 1989; 4(1):28-33. PubMed ID: 2666123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.
    Tortella FC; Ferkany JW; Pontecorvo MJ
    Life Sci; 1988; 42(24):2509-14. PubMed ID: 3374269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of dextromethorphan in rats.
    Gavend M; Mallaret M; Dematteis M; Baragatti G
    Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antitussive effects of dextrorphan, dextromethorphan and phencyclidine.
    Lal J; Krutak-Krol H; Domino EF
    Arzneimittelforschung; 1986 Jul; 36(7):1075-8. PubMed ID: 3768075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.
    Apland JP; Aroniadou-Anderjaska V; Figueiredo TH; De Araujo Furtado M; Braga MFM
    Neurotox Res; 2018 Oct; 34(3):511-524. PubMed ID: 29713995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel neuroprotective effects with O-benzyl derivative of pralidoxime in soman-intoxicated rodents.
    Loke WK; Sim MK; Go ML
    Eur J Pharmacol; 2005 Oct; 521(1-3):59-69. PubMed ID: 16171800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsants for soman-induced seizure activity.
    Shih T; McDonough JH; Koplovitz I
    J Biomed Sci; 1999; 6(2):86-96. PubMed ID: 10087439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of dextrorphan.
    Fossati A; Vimercati MG; Caputo R; Valenti M
    Arzneimittelforschung; 1995 Nov; 45(11):1188-93. PubMed ID: 8929237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.